Headquartered in Conshohocken, PA Fiscal year ends September NYSE: COR cencora.com
Cencora, Inc. (formerly AmerisourceBergen) is a global pharmaceutical solutions organization that partners with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. The company operates through two primary reportable segments: U.S. Healthcare Solutions, which distributes branded and generic pharmaceuticals, specialty products, and healthcare solutions to health systems, physician practices, pharmacies, and other providers; and International Healthcare Solutions, which encompasses European pharmaceutical distribution and global specialty logistics services. Additionally, the company operates other businesses including MWI Animal Health (animal health distribution), Profarma (Brazilian pharmaceutical distribution), and certain consulting and regulatory services through PharmaLex. Cencora completed the acquisition of OneOncology in February 2026, significantly expanding its specialty oncology capabilities, and previously acquired Retina Consultants of America in January 2025. The company also operates Good Neighbor Pharmacy, a national franchise network for independent pharmacies. Cencora is ranked #10 on the Fortune 500 with more than $300 billion in annual revenue and serves customers across the healthcare ecosystem including hospitals, retail pharmacies, specialty practices, and pharmaceutical manufacturers. Updated
The $59 billion drug distributor just put a career logistics operator in the boardroom: Sanchez ran Ryder System as CEO before this seat went effective October 1. Supply chain execution is the whole game in pharmaceutical distribution, and the board now reflects that.
William Blair launched coverage of Cardinal Health (NYSE:CAH | CAH Price Prediction) with an Outperform rating today, framing the pharma distributor as a durable franchise with specialty-led upside. The firm simultaneously initiated…
UnitedHealth Group (NYSE:UNH | UNH Price Prediction) has faced severe headwinds in 2025, with its stock plummeting over 50% from its April high. This decline was driven by a rare first-quarter earnings…
24/7 Wall Street Insights MicroStrategy’s Business Intelligence software is used by many large corporations, such as WalMart. MicroStrategy has intentionally let the software business slow down to focus on Bitcoin (BTC) acquisition,…
Cencora, Inc. (formerly AmerisourceBergen) is a global pharmaceutical solutions organization that partners with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. The company operates through two primary reportable segments: U.S.
24/7 Wall St.'s 12-month price target for COR is $384.92, rated Buy. The Wall Street consensus target is $369.25. COR price prediction →
